Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Tajima

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Cancer Diagnosis & Prognosis|April 11, 2022
Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal CancerChika Mizutani, Nobuhisa Matsuhashi, Hiroyuki Tomita, et al.
Oncology Letters|November 4, 2024
Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancerHirokatsu Hayashi, Itaru Yasufuku, Yuta Sato, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Cancer Diagnosis & Prognosis|April 11, 2022
Predictive Value of the Prognostic Nutritional Index in Neoadjuvant Chemoradiotherapy for Rectal CancerChika Mizutani, Nobuhisa Matsuhashi, Hiroyuki Tomita, et al.
Oncology Letters|November 4, 2024
Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancerHirokatsu Hayashi, Itaru Yasufuku, Yuta Sato, et al.
Pageof 7